Last Updated 21 April 2021.
3 Vaccines Approved for Use in United Kingdom of Great Britain and Northern Ireland
-
Moderna
mRNA-1273- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 46 countries
15 trials in 3 countries
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 83 countries
18 trials in 12 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 91 countries
24 trials in 15 countries
6 Vaccines in Clinical Trials in United Kingdom of Great Britain and Northern Ireland
-
Novavax
NVX-CoV2373- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 6 countries
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 83 countries
18 trials in 12 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 other countries
8 trials in 17 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 91 countries
24 trials in 15 countries
-
Valneva
VLA2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Codagenix Inc
COVI-VAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
1 Vaccines with Trials in United Kingdom of Great Britain and Northern Ireland are No Longer Progressing
-
Imperial
LNP-nCoVsaRNA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country